These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 27448972

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The PI3K pathway impacts stem gene expression in a set of glioblastoma cell lines.
    Martinez E, Vazquez N, Lopez A, Fanniel V, Sanchez L, Marks R, Hinojosa L, Cuello V, Cuevas M, Rodriguez A, Tomson C, Salinas A, Abad M, Holguin M, Garza N, Arenas A, Abraham K, Maldonado L, Rojas V, Basdeo A, Schuenzel E, Persans M, Innis-Whitehouse W, Keniry M.
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):593-604. PubMed ID: 32030510
    [Abstract] [Full Text] [Related]

  • 6. PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells.
    Udawant S, Litif C, Lopez A, Gunn B, Schuenzel E, Keniry M.
    Cells; 2021 Nov 07; 10(11):. PubMed ID: 34831287
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
    Sunayama J, Matsuda K, Sato A, Tachibana K, Suzuki K, Narita Y, Shibui S, Sakurada K, Kayama T, Tomiyama A, Kitanaka C.
    Stem Cells; 2010 Nov 07; 28(11):1930-9. PubMed ID: 20857497
    [Abstract] [Full Text] [Related]

  • 10. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA, Stechishin OD, Nguyen SA, Lun XQ, Cairncross JG, Weiss S.
    Clin Cancer Res; 2014 Nov 15; 20(22):5756-67. PubMed ID: 25316808
    [Abstract] [Full Text] [Related]

  • 11. A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.
    Ströbele S, Schneider M, Schneele L, Siegelin MD, Nonnenmacher L, Zhou S, Karpel-Massler G, Westhoff MA, Halatsch ME, Debatin KM.
    PLoS One; 2015 Nov 15; 10(6):e0131670. PubMed ID: 26121251
    [Abstract] [Full Text] [Related]

  • 12. Migration pattern, actin cytoskeleton organization and response to PI3K-, mTOR-, and Hsp90-inhibition of glioblastoma cells with different invasive capacities.
    Memmel S, Sisario D, Zöller C, Fiedler V, Katzer A, Heiden R, Becker N, Eing L, Ferreira FLR, Zimmermann H, Sauer M, Flentje M, Sukhorukov VL, Djuzenova CS.
    Oncotarget; 2017 Jul 11; 8(28):45298-45310. PubMed ID: 28424411
    [Abstract] [Full Text] [Related]

  • 13. Evidence for AKT-independent regulation of FOXO1 and FOXO3 in haematopoietic stem and progenitor cells.
    Liang R, Rimmelé P, Bigarella CL, Yalcin S, Ghaffari S.
    Cell Cycle; 2016 Jul 11; 15(6):861-7. PubMed ID: 26929388
    [Abstract] [Full Text] [Related]

  • 14. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
    Friedman MD, Jeevan DS, Tobias M, Murali R, Jhanwar-Uniyal M.
    Oncol Rep; 2013 Oct 11; 30(4):1645-50. PubMed ID: 23877261
    [Abstract] [Full Text] [Related]

  • 15. FOXO1 and FOXO3a sensitize non-small-cell lung cancer cells to cisplatin-induced apoptosis independent of Bim.
    Sun T, Zhang J, Deng B, Fan X, Long T, Jin H, Tao S, Kang P, Tan Q.
    Acta Biochim Biophys Sin (Shanghai); 2020 Dec 29; 52(12):1348-1359. PubMed ID: 33167006
    [Abstract] [Full Text] [Related]

  • 16. PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.
    Chen J, Shao R, Li F, Monteiro M, Liu JP, Xu ZP, Gu W.
    Clin Exp Pharmacol Physiol; 2015 Dec 29; 42(12):1317-26. PubMed ID: 26399781
    [Abstract] [Full Text] [Related]

  • 17. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells.
    Shukla S, Rizvi F, Raisuddin S, Kakkar P.
    Free Radic Biol Med; 2014 Nov 29; 76():185-99. PubMed ID: 25128467
    [Abstract] [Full Text] [Related]

  • 18. Enhanced efficacy of histone deacetylase inhibitor panobinostat combined with dual PI3K/mTOR inhibitor BEZ235 against glioblastoma.
    Meng W, Wang B, Mao W, Wang J, Zhao Y, Li Q, Zhang C, Ma J.
    Nagoya J Med Sci; 2019 Feb 29; 81(1):93-102. PubMed ID: 30962658
    [Abstract] [Full Text] [Related]

  • 19. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
    Liu J, Liu L, Xue Y, Meng F, Li S, Wang P, Liu Y.
    Biochem Pharmacol; 2014 Jun 15; 89(4):477-89. PubMed ID: 24792437
    [Abstract] [Full Text] [Related]

  • 20. FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity.
    Sunayama J, Sato A, Matsuda K, Tachibana K, Watanabe E, Seino S, Suzuki K, Narita Y, Shibui S, Sakurada K, Kayama T, Tomiyama A, Kitanaka C.
    Stem Cells; 2011 Sep 15; 29(9):1327-37. PubMed ID: 21793107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.